Dynamic carbon re-routing between catabolic and anabolic metabolism is an essential element of cellular transformation associated with tumour formation and immune cell activation. Such bioenergetic adaptations are important for cellular function and therefore require tight control. Carbohydrate phosphorylation has been proposed as a rate-limiting step of several metabolic networks. The recent identification of a sedoheptulose kinase indicated that free sedoheptulose is a relevant and accessible carbon source in humans. Furthermore, the bioavailability of its phosphorylated form, sedoheptulose 7-phosphate, appears to function as a rheostat for carbon-flux at the interface of glycolysis and the pentose phosphate pathway. In the present paper, we review reports of sedoheptulose metabolism, compare it with glucose metabolism, and discuss the regulation of sedoheptulose kinase as mechanism to achieve bioenergetic reprogramming in cells.
Sedoheptulose kinase regulates cellular carbohydrate metabolism by sedoheptulose 7-phosphate supply Introduction
Cellular physiology is defined by the co-ordinated interplay between oxygen consumption and carbohydrate, fat and amino acid metabolism to balance anabolic and catabolic biochemical reactions according to the energetic demands of the cell. Glycolysis and the PPP (pentose phosphate pathway, also known as the monohexose phosphate shunt) represent major pathways of primary carbohydrate metabolism. They are tightly connected, reflected by the sharing of several pathway intermediates. The PPP, primarily located in the cytosol, can be divided into the oxidative and non-oxidative branches [1] . The oxidative branch utilizes G6P (glucose 6-phosphate) in three irreversible reactions to generate CO 2 , NADPH and ribulose 5-phosphate. Transketolase and transaldolase of the non-oxidative branch reversibly interconvert carbon phosphates to form precursor molecules for subsequent biochemical reactions. These reversible carbon scrambling events form a substrate bridge between PPP and glycolysis. Defects in transketolase and transaldolase are reported in disorders such as liver disease, Alzheimer's disease, male sterility and cancer [2] [3] [4] . Co-ordinated carbon scrambling specifically tunes the carbon flux to independently regulate both precursor formation and redox state according to cellular demands. Sedoheptulose is a relatively unknown Key words: carbohydrate metabolism, macrophage activation, pentose phosphate pathway, redox regulation, sedoheptulose kinase, sedoheptulose 7-phosphate. Abbreviations used: CARKL, carbohydrate kinase-like gene; DHAP, dihydroxyacetone phosphate; E4P, erythrose 4-phosphate; F1,6BP, fructose 1,6-bisphosphate; F1P, fructose 1-phosphate; F2,6BP, fructose 2,6-bisphosphate; F6P, fructose 6-phosphate; G1,6BP, glucose 1,6-bisphosphate; G3P, glyceraldehyde 3-phosphate; G6P, glucose 6-phosphate; GS, 7-O-galloylsedoheptulose; LPS, lipopolysaccharide; PFK, phosphofructokinase; PPP, pentose phosphate pathway; R5P, ribose 5-phosphate; S1,7BP, sedoheptulose 1,7-bisphosphate; S7P, sedoheptulose 7-phosphate; SBPase, sedoheptulose-1,7-bisphosphatase; TRPV1, transient receptor potential vanilloid 1; X5P, xylulose 5-phosphate. 1 To whom correspondence should be addressed (arvand.haschemi@meduniwien.ac.at) metabolite compared with its phosphorylated form, S7P (sedoheptulose 7-phosphate), which is recognized as an intermediate molecule of primary glucose metabolism. The natural existence of sedoheptulose, a keto-heptose, was first reported in plants [5] and was subsequently identified in human urine [6] , blood spots [7] and, recently, within mouse cells [8] . S7P is derived from the transketolase-catalysed conversion of R5P (ribose 5-phosphate) and X5P (xylulose 5-phosphate) [9] . This reaction occurs in the non-oxidative arm of the PPP and generates G3P (glyceraldehyde 3-phosphate), a key glycolytic intermediate, in addition to S7P. G3P and S7P are also produced by transaldolase using F6P (fructose 6-phosphate) and E4P (erythrose 4-phosphate) as substrates. S7P is thus a crucial intermediate in the non-oxidative PPP and S7P bioavailability therefore contributes to cellular carbon flux. In previous studies, data from several groups have indicated that sedoheptulose kinase may also produce S7P by direct phosphorylation of sedoheptulose [8, 10, 11] . This finding demonstrated the unexpected existence of an additional carbon source, sedoheptulose, which actively participates in cellular carbon metabolism. In the present paper, we introduce sedoheptulose kinase as a rate-limiting enzyme of primary carbohydrate metabolism. We compare heptose with hexose metabolism and discuss the importance of sedoheptulose kinase regulation for balancing cellular glucose consumption, redox regulation and nucleotide precursor formation.
Sedoheptulose kinase

Identification of carbohydrate kinase-like gene
Touchman et al. [12] reported a novel open reading frame located on chromosome 17p13, which is deleted in nephropathic cystinosis patients harbouring a common genomic 57 kb deletion. The sequence of the putative gene contains moderately conserved FGGY carbohydrate kinase domains and was therefore termed CARKL (carbohydrate kinase-like gene) or SHPK. CARKL mRNA is highly expressed in human liver, kidney, pancreas and heart tissue [12, 13] . Cystinosis, if left untreated, is a lethal autosomal recessive lysosomal storage disorder, which results in the accumulation of cystine residues in lysosomes and consequently, crystal formation [14] . This severe pathological event has been attributed to inactivation of the nephropathic cystinosis gene (CTNS) [15] . In addition to CTNS and CARKL, the TRPV1 (transient receptor potential vanilloid 1) gene was significantly affected by the 57 kb deletion [16] . Thus evaluating CARKL deletion separate from CTNS and also TRPV1 deficiency may be required to understand the clinical heterogeneity of cystinosis [10] .
CARKL encodes a sedoheptulose kinase
Wamelink et al. [10] observed high concentrations of sedoheptulose in the urine of cystinosis patients associated with the genomic 57 kb deletion. They also reported that CARKL deficiency in cystinosis patients correlated with significantly decreased phosphorylation of sedoheptulose exogenously added to crude fibroblast protein homogenates. The authors concluded that the CARKL-encoded protein might be responsible for this observation. This hypothesis was further supported by Kardon et al. [11] , who demonstrated the specificity of the recombinant CARKL protein for sedoheptulose, whereas the structural analogues altrose and mannoheptulose showed only very weak or no activity in an enzymatic ADP formation assay. Finally, our group reported recently a direct CARKL kinase reaction, which formed a single sedoheptulose phosphate in vitro [8] . Subsequent purification of the reaction product and multi-NMR analysis precisely identified the sedoheptulose C-7 atom as the phosphate acceptor site [8] . These sets of experiments provided clear evidence that CARKL is indeed a sedoheptulose kinase that produces S7P from free sedoheptulose.
Sedoheptulose kinase gene organization
In humans, CARKL is located on the negative strand of chromosome 17, whereas the mouse variant resides on the positive strand of chromosome 11. In both species, splicing of seven exons forms a mature mRNA (∼3.8 and ∼2.8 kb in human and mouse respectively) with short 5 and long 3 UTRs (untranslated regions). Additional CARKL transcripts may also exist, although their properties and functions remain unknown [12] .
Sedoheptulose kinase protein
The CARKL mRNA coding region translates to a ∼51 kDa protein, which co-localizes with G6P dehydrogenase in the cytoplasm [8, 12] . Sedoheptulose kinase is composed of 478 amino acids in humans and 476 amino acids in mice and shares a 92.5 % interspecies similarity and 87 % identity (Emboss Needle alignment, http://www.ebi.ac.uk/Tools/psa/). A phylogenetic tree illustrates the evolutionary relationship of CARKL to several other human carbohydrate kinases ( Figure 1A ). Two independent proteomics screens also identified sedoheptulose kinase as a ubiquitin-modified protein [17, 18] . Therefore it is highly likely that this kinase is sensitive to post-translational regulation, which may affect its activity. A protein structure derived from in silico comparative modelling suggested a putative catalytic cleft located in the centre of the protein, two potential sedoheptulose-binding sites and a highly conserved ATPase domain [8] . Mutational analysis confirmed the functional importance of this ATPase domain and identified additional amino acids that were structurally important. At present, we remain reliant on such modelling approaches until better structural data become available for extrapolating the molecular mechanics of this kinase.
Sedoheptulose and S7P
Free sedoheptulose can be either diet-derived from fruits and vegetables or formed enzymatically by the dephosphorylation of endogenously produced S7P [11, 19] ( Figure 1B ). To date, no specific sedoheptulose transporter or S7P-specific phosphatase has been reported. Other bioactive heptoses include the phenolic compound GS (7-O-galloyl-sedoheptulose) and mannoheptulose. GS was reported to be protective in diabetic injury of the kidney by alleviating inflammatory responses [20] . Mannoheptulose is an isomer of sedoheptulose and a potent hexokinase inhibitor commonly found in avocados [21, 22] . Subcutaneous injection of mannoheptulose increased ketone body formation in fasted rats, whereas sedoheptulose injection had the opposite effect within 1 h [23] . However, the most relevant form of sedoheptulose for carbohydrate metabolism might be its phosphorylated form S7P. In the mid-1950s, Horecker et al. [24, 25] and Gunsalus et al. [26] identified S7P as the product of a transaldolase and transketolase reaction and suggested that S7P was an intermediate that facilitated hexose reformation from PPP-derived pentose. This was further supported by the observation of increased S7P formation in the liver extracts of various animals after incubation with nucleosides [27, 28] . Therefore the identification of a sedoheptulose kinase as a additional S7P source was somewhat unexpected. In fibroblasts, the ratio of S7P to the sum of G6P and F6P was reported to be approximately 1:10 [29] . In Krebs ascites tumour cells, the S7P concentration is approximately half that of F6P and appears to be more abundant in these cells than in fibroblasts [30] . In calf liver, S7P was reported to account for up to 10 % of all carbohydrate phosphates [28] . This finding is supported by the observation of high CARKL expression in the human liver [12] . However, we have no information regarding the extent to which CARKL contributes to net S7P formation. Thus it is essential to accurately measure both the sedoheptulose and S7P concentrations in various tissues and cell types with state-of-the-art quantification methods. In addition to S7P, sedoheptulose 1-phosphate was also reported as a sedoheptulose metabolite, but its physiological role and formation remains speculative [31] .
Cellular sedoheptulose kinase and metabolism
Sedoheptulose kinase phosphorylates free sedoheptulose, which enables cells to directly route sedoheptulose to carbohydrate metabolism, similar to hexokinase and glucose. This finding indicates that sedoheptulose is a direct carbon source that feeds primary carbohydrate catabolism and anabolism, where CARKL constitutes its entry point. This also raises questions regarding the extent to which cells consume and rely on sedoheptulose and the mechanism by which glucose and sedoheptulose metabolism are interrelated. In the next section, we review articles that are related to cellular CARKL function to provide a biological context and information that may help to appreciate the complexity of these metabolic networks.
Metabolism of carbohydrate phosphates
To determine the role of sedoheptulose kinase and to integrate its function into established primary carbohydrate metabolism, we compared sedoheptulose with glucose and fructose because these compounds all exist as free carbohydrates and phosphorylated forms. We present a non-linear catabolic network on the basis of participating carbohydrate phosphates, which is regulated by (i) phosphorylation events, (ii) carbohydrate phosphate interconversion rates, and (iii) the formation and consumption of bisphosphates (Figure 2) .
To enter metabolism, free carbohydrates are energetically activated by an initial phosphorylation event. Hexokinase phosphorylates glucose to form G6P and is a key determinant of cellular glucose flux [32] . Fructose is phosphorylated by ketohexokinase to form F1P (fructose 1-phosphate), which must first be converted by aldolase into glyceraldehyde and DHAP (dihydroxyacetone phosphate) [33] . DHAP can then directly enter the carbon cycle, whereas glyceraldehyde must be further phosphorylated. The formation of S7P by sedoheptulose kinase, in a manner analogous to G6P formation by hexokinase, enables free sedoheptulose to readily enter the catabolic system (Figure 2) .
After free carbohydrates are phosphorylated, they are retained inside the cell, increase in concentration and become possible substrates for aldolase, transketolase or transaldolase. Regulation of these primarily reversible reactions can specifically interconvert carbohydrate phosphates (carbon scrambling) according to cellular needs. A prime example for this is represented by the interface of glycolysis and the non-oxidative PPP. G6P is converted into F6P and reacts with E4P to form S7P and G3P, which can subsequently generate two pentose phosphates. This series of reversible reactions produces C 3 , C 4 , C 5 , C 6 and C 7 units and is most likely to be determined by the kinetic properties and subcellular localization of enzymes and the concentrations of the respective substrates. The regulation of carbon scrambling to generate specific metabolic precursors provides an additional level of metabolic regulation (Figures 2 and 3A) .
A third level of regulation is represented by generation and consumption of carbohydrate bisphosphates. Examples of carbohydrate bisphosphates found in mammals include G1,6BP (glucose 1,6-bisphosphate), F1,6BP (fructose 1,6-bisphosphate), F2,6BP (fructose 2,6-bisphosphate) and the reported but rarely considered S1,7BP (sedoheptulose 1,7-bisphosphate) [34] [35] [36] [37] . The formation of S1,7BP can be partially explained by the reversible aldolase-driven condensation of E4P and DHAP [38] . It was also reported that rat and rabbit liver fractions, enriched for PFK (phosphofructokinase) activity, formed S1,7BP in the presence of S7P and ATP [37, 39] . However, the kinase responsible has not been identified. Karadsheh et al. [39] further reported a competitive inhibition of F6P phosphorylation in the presence of very high S7P concentrations. Interestingly, fractions containing FBPase (fructose-1,6-bisphosphatase) were also reported to possess SBPase (sedoheptulose-1,7-bisphosphatase) activity [40, 41] . Together, these results provide preliminary evidence for the coexistence of the hexose-and heptose-(bis)phosphate shunts ( Figure 3B) . Notably, high glucose levels or incubation with F2,6BP augmented S1,7BP formation in perfused rat liver and in rat liver cytosol respectively [36, 37] . Glucagon, in contrast with high glucose, favoured S1,7BP dephosphorylation and therefore S7P formation [36] . These results indicate that sedoheptulose metabolism is sensitive to hormonal control. Carbohydrate bisphosphates not only are important allosteric regulators of metabolism, but also Our simplified model compares fructose, glucose and sedoheptulose catabolism by highlighting reversible and rate-limiting ATP-coupled reactions. This metabolic network is based on free carbohydrates and their activation by phosphorylation to form F1P, F6P, G6P and S7P. Subsequently, certain carbohydrates can become possible substrates for interconversion of carbohydrate phosphate by TK (transketolase), transaldolase (TA) and aldolase or, as is the case for G6P, be consumed by ox-PPP (oxidative PPP). F6P and S7P can directly contribute to non-ox-PPP (non-oxidative-PPP). Fructose phosphorylated by KHK (ketohexokine) forms DHAP and glyceraldehyde in the presence of aldolase. Glyceraldehyde can be further phosphorylated to G3P or used for triglyceride synthesis [50] . Bisphosphorylation constitutes an additional regulatory mechanism. PFK-1 phosphorylates F6P to F1,6BP, whereas PFK-2 forms F2,6BP. These bisphosphates can be reconverted into their respective monophosphates by phosphofructose bisphophatases. A similar regulation pattern was reported for S7P and S1,7BP (see the text) [34] [35] [36] [37] [38] [39] [40] [41] . Aldolase uses F1,6BP and S1,7BP as substrates to form DHAP and G3P or DHAP and E4P respectively. These reactions are reversible and can thereby regulate bioavailability of carbohydrate phosphates to provide reaction partner for the non-ox-PPP. The non-ox-PPP scrambles carbon phosphates according to cellular demands for critical intermediates of three to seven carbon atoms in length (G3P, E4P, R5P, F6P and S7P).
serve as carbon substrates. Aldolase converts F1,6BP into two triose phosphates (see glycolysis) and S1,7BP into E4P and DHAP, which can then re-enter the carbon substrate bridge (discussed above) [38] . In plants, during the regenerative phase of the Calvin cycle, a specific SBPase converts S1,7BP into S7P for ribulose bisphosphate reformation to provide cofactors for carbon fixation [42] . In yeast, SBPase SHB17 dephosphorylates S1,7BP to S7P and is essential for riboneogenesis in the absence of NADPH production [43] . Interestingly, no specific SBPase has been reported in humans, and no sedoheptulose kinase has been identified in the yeast genome.
Sedoheptulose kinase participates in metabolic regulation
The regulation of glycolysis has been extensively studied and illustrates how various regulatory mechanisms coexist to ensure the proper regulation of this process. Hormonal control, allosteric regulation, carbohydrate isomerism, feedback and amplification loops, as well as post-translational modifications and subcellular localization of the participating enzymes, are all decisive control elements for carbon flux [9, 44] . This highly sophisticated apparatus maintains cellular physiology and allows for the synchronous adaptation of cellular carbon usage to systemic glucose levels, which are transduced by hormones and the intracellular energy status, such as the AMP/ATP ratio. The regulation of the PPP compared with glycolysis is less well defined. Reversible reactions allow the non-oxidative PPP to operate in various modes and thus demand tight regulation [45] . CARKL is likely to be a candidate for directing these fluxes by providing an S7P supply independently of glucose. Increased CARKL expression in a mouse macrophage cell line resulted in reduced G3P, X5P and R5P steady-state levels, whereas CARKL knockdown showed the reverse effect [8] . Notably, the basal sedoheptulose levels were not changed by CARKL perturbation. The S7P levels were not changed by overexpression, but decreased significantly by CARKL loss, indicating S7P as a rate-limiting cofactor for glycolysis-derived G3P distribution ( Figure 3B ). Glucose incubation in tumour cells of Krebs ascites tumour cells resulted in a G3P concentration approximately 5-fold higher Increased glycolytic G3P and CARKL-derived S7P will favour the formation of C5P and/or C6P molecules. In accordance to non-equilibrium thermodynamics, if the S7P concentration falls (i.e. after CARKL knockdown), equilibrium shifts in favour to S7P formation and therefore flux through non-oxidative PPP will increase. However, this hypothesis needs further validation. Flux direction appears to be multifactorial as well as context-dependent and therefore can not be indicated here. Lower panel: in addition to the S7P/G3P ratio, the S1,7BP/F1,6BP ratio appears to contain biologically relevant information (see main text, [34] [35] [36] [37] [38] [39] [40] [41] ). S7P can be phosphorylated and was reported to compete in high concentration with F6P for phosphorylation [39] . High glucose or F2,6BP stimulated S1,7BP formation, whereas glucagon favoured S7P build-up [36, 37] . Aldolase converts bisphosphates into carbohydrate monophosphate intermediates to fuel non-oxidative PPP. S1,7BP contributes E4P and DHAP, whereas F1,6BP donates two triose phosphates. This ratio might also be important to regulate non-oxidative PPP flux. These simplified schematic illustrations do not consider any regulation other than indicated (i.e. carbohydrate isomerism).
than S7P [30] . PPP-derived S7P and G3P are produced in equimolar amounts even when the flux rate increases. We hypothesize that S7P supply is rate-limiting for carbonscrambling events and thereby exerts its control mechanism. Therefore the regulation of S7P availability might be the mechanism by which CARKL modulates non-oxidative PPP flux.
Sedoheptulose kinase regulates macrophage activation
In a functional kinase screen for novel regulators of macrophage activation, sedoheptulose kinase was found to repress LPS (lipopolysaccharide)-induced tumour necrosis factor α secretion [8] . In the same screen, overexpression of hexokinase, ketohexokinase and phosphofructokinase had the opposite effect. To functionally mature, macrophages increase F2,6BP formation and switch to aerobic glycolysis (known as the Warburg effect) at the expense of mitochondrial respiration (reviewed in [46] ). Data derived from dynamic metabolic flux analyses at 1 h after macrophage activation indicated an increased glycolytic and oxidative PPP flux and the rerouting of a large amount of glycolytic carbon via the non-oxidative PPP to form ribose and hexose phosphates. In response to activation, endogenous CARKL expression is repressed in macrophages and monocytes, and this response is conserved both in vivo and in vitro in humans and mice [8] . In resting macrophages, knockdown of endogenous CARKL significantly increased extracellular acidification rates and simultaneously reduced mitochondrial oxygen consumption rates, thereby mimicking the metabolic phenotype observed after activation by LPS [8] . High S7P levels were reported to inhibit hexose phosphate isomerase and competitively block F6P phosphorylation [39, 47] . Reduced S7P levels might therefore favour glycolysis. Moreover, ectopic CARKL expression repressed LPS-induced macrophage activation and resulted in insufficient cellular redox power and blunted intracellular superoxide formation [8] . If both glycolysis and CARKL-derived S7P are high, as observed in activated macrophages ectopically expressing CARKL, S7P and ribose phosphate and oxidized redox couples accumulate, most likely through feedback inhibition of oxidative PPP [8] . However, the exact mechanism and kinetics of CARKLregulated carbon fluxes during macrophage activation remain to be determined. We speculate that physiological metabolic reprogramming, such as immune cell activation, tunes multiple metabolic regulators simultaneously and in precisely timed, to adapt carbon flux according to cellular demands. It is interesting to note that S7P not only is involved in endotoxininduced macrophage activation, but also constitutes a core molecule for LPS biosynthesis in most Gram-negative bacteria [48] .
Conclusion
In addition to rate-limiting ATP-coupled reactions, concentration gradients along metabolic pathways provide the thermodynamic force that is essential for proper flux regulation [9, 49] . Sedoheptulose kinase appears to contribute to direct metabolic flux by ATP-dependent generation of cellular S7P, a direct product and substrate of glucose metabolism. Most experiments discussed in the present review represent in vitro data. Therefore it will be important to determine the basic parameters of heptose metabolism in vivo (e.g. sedoheptulose absorption). We have recently established the first genetic mouse models of CARKL to test its function in vivo and to translate its regulation to medicine.
